Page last updated: 2024-10-27

fluoxetine and Hemorrhagic Fever, Ebola

fluoxetine has been researched along with Hemorrhagic Fever, Ebola in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Hemorrhagic Fever, Ebola: A highly fatal, acute hemorrhagic fever caused by EBOLAVIRUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kummer, S1
Lander, A1
Goretzko, J1
Kirchoff, N1
Rescher, U1
Schloer, S1

Other Studies

1 other study available for fluoxetine and Hemorrhagic Fever, Ebola

ArticleYear
Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection
    Emerging microbes & infections, 2022, Volume: 11, Issue:1

    Topics: Antiviral Agents; Cholesterol; Ebolavirus; Endosomes; Fluoxetine; Hemorrhagic Fever, Ebola; Humans;

2022